Login
$BMY
$61.61 +$0.13 (0.21%) Close

Ownership

13F as of Q2 2026 · 2.04B shares outstanding

Who owns BMY?

By type of holder
Institutions 82.1% Insiders 0.0% Everyone else 18.0%
Concentration Top 10 holders own 37.3%
BlackRock, Inc. 8.8% · Vanguard Capital Management LLC 6.5%
Institutional ownership
82.1%
+2.8 pts vs last qtr
Institutional holders
2,523
-24 vs last qtr
Net shares bought
+56.2M
by institutions in Q2 2026
New / sold out
175 / 199
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Norges Bank NEW +36.9M
  • Price T Rowe Associates Inc /MD/ +21.5M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Jpmorgan Chase & Co −20.8M
  • Millennium Management LLC −5.8M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$2.29M
3 notices from 3 people
Shares covered
36.7K
0.00% of the company
Arranged in advance
81%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$925.3K$1.9MNovDecJanFebMarApr 2026: $1.9M under a 10b5-1 planAprMayJunJulAug 2026: $33.8K without a planAugSep 2026: $403.5K without a planSepOct
Largest proposed sellers
  • Elkins David V Officer 10b5-1 $1.85M
  • Massacesi Cristian Officer $403K

Sign up to see all 3.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+21.4%
+2.18% a year
Each share's claim on the business
−17.6%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$31.3B vs $4.46B
over 10 fiscal years
Diluted shares, split-adjusted
1.59B1.93B2.28B2016: 1.68B shares'162017: 1.65B shares'172018: 1.64B shares'182019: 1.71B shares'192020: 2.26B shares'202021: 2.25B shares'212022: 2.15B shares'222023: 2.08B shares'232024: 2.03B shares'242025: 2.04B shares'25
Buybacks Stock-based comp
$0$4.0B$8.0B2016 buybacks: $231.0M2016 stock comp: $205.0M'162017 buybacks: $2.47B2017 stock comp: $199.0M'172018 buybacks: $320.0M2018 stock comp: $221.0M'182019 buybacks: $7.3B2019 stock comp: $441.0M'192020 buybacks: $1.55B2020 stock comp: $779.0M'202021 buybacks: $6.29B2021 stock comp: $583.0M'212022 buybacks: $8.0B2022 stock comp: $457.0M'222023 buybacks: $5.16B2023 stock comp: $518.0M'232024 buybacks: $02024 stock comp: $507.0M'242025 buybacks: $02025 stock comp: $553.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years89% 3–5 years2% 1–3 years5% Under 1 year5%
Quarterly turnover
7.3%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting BMY on Form 13F
B
BlackRock, Inc.
Shares
180.4M
% of company
8.83%
Change vs last qtr
+8.7M (+5.1%)
Held since
≤2021
VC
Vanguard Capital Management LLC
Shares
133.3M
% of company
6.53%
Change vs last qtr
+1.0M (+0.8%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Bristol-Myers Squibb Company, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting BMY on Form N-PORT; together they hold 30.9% of the company
VT
Position value
$3.74B
% of company
3.17%
% of the fund
0.16%
As of
June 30, 2026
V5
Vanguard Index Funds
Position value
$3.05B
% of company
2.59%
% of the fund
0.18%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Bristol-Myers Squibb Company and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support